Path Traversal in AWS Aws-Healthomics-Mcp-Server
CVE-2026-15415
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
EPSS: 0.004 (28.1th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 5.5 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N.
Affected products
- Aws Aws-healthomics-mcp-server — versions 0
Weakness classification (CWE)
References
- ff89ba41-3aa1-4d27-914a-91399e9639e5 (release-notes, patch)
- ff89ba41-3aa1-4d27-914a-91399e9639e5 (vendor-advisory)
- ff89ba41-3aa1-4d27-914a-91399e9639e5 (release-notes)
Frequently asked questions
- What is CVE-2026-15415?
- CVE-2026-15415 is a medium-severity vulnerability in AWS Aws-Healthomics-Mcp-Server, classified under Relative Path Traversal. CVSS score: 5.5/10. Published 2026-07-17.
- How severe is CVE-2026-15415?
- Medium severity. CVSS v3 base score is 5.5 out of 10.